6533b82dfe1ef96bd1290b36

RESEARCH PRODUCT

Signature of Circulating Biomarkers in Recurrent Non-Infectious Anterior Uveitis. Immunomodulatory Effects of DHA-Triglyceride. A Pilot Study

Jose Javier Garcia-medinaJosé E. O’connorRicardo P. Casaroli-maranoRicardo P. Casaroli-maranoMar Valero-velloMaria D Pinazo-duranMaria D Pinazo-duranCristina Peris-martínezMaribel Lopez-galvezVicente Zanon-morenoVicente Zanon-morenoManuel Díaz-llopisSilvia M. Sanz-gonzálezSilvia M. Sanz-gonzález

subject

0301 basic medicineMedicine (General)medicine.medical_specialtyClinical BiochemistryÀcids grassos omega-3GastroenterologyArticlerecurrent anterior non-infectious uveitisUveitis03 medical and health scienceschemistry.chemical_compoundR5-9200302 clinical medicineOral administrationInternal medicineOmega-3 fatty acidsMedicineTriglicèridsStage (cooking)Triglyceridesomega-3 fatty acidsTriglyceridebusiness.industryInterleukintriglyceride of docosahexaenoic acidmedicine.diseasecytokinesCirculating biomarkers030104 developmental biologychemistryDocosahexaenoic acidUveïtis030221 ophthalmology & optometryTumor necrosis factor alphabusinessUveitis

description

The purpose of this study was to identify circulating biomarkers of recurrent non-infectious anterior uveitis (NIAU), and to address the anti-inflammatory effects of triglyceride containing docosahexaenoic acid (DHA-TG). A prospective multicenter study was conducted in 72 participants distributed into: patients diagnosed with recurrent NIAU in the quiescence stage (uveitis group (UG)

https://doi.org/10.3390/diagnostics11040724